Prelude Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $9.9k | 7.7k | 1.28 |
| 2024-09-30 | $13k | 6.1k | 2.07 |
| 2024-06-30 | $22k | 5.8k | 3.81 |
| 2024-03-31 | $25k | 5.3k | 4.74 |
| 2023-12-31 | $20k | 4.6k | 4.27 |
| 2023-09-30 | $11k | 3.6k | 3.09 |
| 2023-06-30 | $19k | 4.2k | 4.50 |
| 2022-12-31 | $2.1k | 342 | 6.04 |
| 2022-09-30 | $0 | 371 | 0.00 |
| 2022-06-30 | $0 | 187 | 0.00 |
| 2022-03-31 | $1.0k | 100 | 10.00 |
| 2021-12-31 | $39k | 3.2k | 12.36 |
| 2021-09-30 | $1.6k | 43 | 37.04 |
| 2021-06-30 | $1.6k | 43 | 37.04 |
| 2021-03-31 | $44k | 1.0k | 43.52 |
| 2020-12-31 | $344k | 4.8k | 71.56 |